 |
|||||||||
|
|||||||||
 |
|||||||||
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Panel Orders |
||||||||||
March 2012 Hearing Session |
||||||||||
Motions to Centralize -- New MDLs [PDF] |
||||||||||
|
MDL No. 2373 -- IN RE: H&R Block Refund Anticipation Loan Litigation |
||||||||||
|
MDL No. 2346 -- IN RE: Northeast Contaminated Beef Products Liability Litigation |
||||||||||
|
MDL No. 2345 -- IN RE: Exterior Metal Siding Warranty Litigation |
||||||||||
|
MDL No. 2344 -- IN RE: Bear Creek Technologies, Inc., ('722) Patent Litigation |
||||||||||
|
MDL No. 2343 -- IN RE: Skelaxin (Metaxalone) Antitrust Litigation |
||||||||||
|
MDL No. 2342 -- IN RE: Zoloft (Sertraline Hydrochloride) Products Liability Litigation |
||||||||||
|
MDL No. 2341 -- IN RE: Building Products of Canada Corp. Organic Shingles Products Liability Litigation |
||||||||||
|
MDL No. 2340 -- IN RE: Fresh Dairy Products Antitrust Litigation |
||||||||||
|
MDL No. 2339 -- IN RE: Teamster Car Hauler Product Liability Litigation |
||||||||||
|
MDL No. 2338 -- IN RE: MF Global Holdings Ltd. Investment Litigation |
||||||||||
|
MDL No. 2337 -- IN RE: Royal Alliance Associates, Inc., Securities Litigation |
||||||||||
|
MDL No. 2336 -- IN RE: Plasma Arc Technologies, Inc., Due Diligence Litigation |
||||||||||
|
MDL No. 2335 -- IN RE: Bank of New York Mellon Corp. Foreign Exchange Transactions Litigation |
||||||||||
|
MDL No. 2334 -- IN RE: Refund Anticipation Loan Litigation |
||||||||||
|
MDL No. 2333 -- IN RE: MI Windows and Doors, Inc., Products Liability Litigation |
||||||||||
|
MDL No. 2332 -- IN RE: Lipitor Antitrust Litigation |
||||||||||
|
MDL No. 2331 -- IN RE: Propecia (Finasteride) Products Liability Litigation |
||||||||||
|
MDL No. 2330 -- IN RE: Carrier IQ, Inc., Consumer Privacy Litigation |
||||||||||
|
MDL No. 2328 -- IN RE: Pool Products Distribution Market Antitrust Litigation |
||||||||||
Motions in Previously-Centralized MDLs [PDF] |
||||||||||
|
MDL No. 2308 -- IN RE: Skechers Toning Shoe Products Liability Litigation |
||||||||||
|
MDL No. 2272 -- IN RE: Zimmer NexGen Knee Implant Products Liability Litigation |
||||||||||
|
MDL No. 2270 -- IN RE: CertainTeed Fiber Cement Siding Litigation |
||||||||||
|
MDL No. 2265 -- IN RE: Countrywide Financial Corp. Mortgage-Backed Securities Litigation |
||||||||||
|
MDL No. 2244 -- IN RE: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation |
||||||||||
|
MDL No. 2243 -- IN RE: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II) |
||||||||||
|
MDL No. 2226 -- IN RE: Darvocet, Darvon and Propoxyphene Products Liability Litigation |
||||||||||
|
MDL No. 2197 -- IN RE: DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation |
||||||||||
|
MDL No. 2179 -- IN RE: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010 |
||||||||||
|
MDL No. 2068 -- IN RE: Light Cigarettes Marketing and Sales Practices Litigation |
||||||||||
|
MDL No. 2009 -- IN RE: Regions Morgan Keegan Securities, Derivative and Employee Retirement Income Security Act (ERISA) Litigation |
||||||||||
|
MDL No. 1932 -- IN RE: Family Dollar Stores, Inc., Wage and Hour Employment Practices Litigation |
||||||||||
|
MDL No. 1909 -- IN RE: Gadolinium Contrast Dyes Products Liability Litigation |
||||||||||
|
MDL No. 1836 -- IN RE: Mirapex Products Liability Litigation |
||||||||||
|
MDL No. 1699 -- IN RE: Bextra and Celebrex Marketing, Sales Practices and Products Liability Litigation |
||||||||||
|
MDL No. 1626 -- IN RE: Accutane (Isotretinoin) Products Liability Litigation |
||||||||||
|
MDL No. 875 -- IN RE: Asbestos Products Liability Litigation (No. VI) - Bell |
||||||||||
|
MDL No. 875 -- IN RE: Asbestos Products Liability Litigation (No. VI) - Taylor |
||||||||||
|
MDL No. 875 -- IN RE: Asbestos Products Liability Litigation (No. VI) - Kovary |
||||||||||
|
MDL No. 875 -- IN RE: Asbestos Products Liability Litigation (No. VI) - Musselman |
||||||||||
|
MDL No. 875 -- IN RE: Asbestos Products Liability Litigation (No. VI) - Crane Co.’s Motion to Modify |
||||||||||